A new antibiotic selectively kills Gram-negative pathogens
Top Cited Papers
- 20 November 2019
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 576 (7787) , 459-464
Abstract
The current need for novel antibiotics is especially acute for drug-resistant Gram-negative pathogens1,2. These microorganisms have a highly restrictive permeability barrier, which limits the penetration of most compounds3,4. As a result, the last class of antibiotics that acted against Gram-negative bacteria was developed in the 1960s2. We reason that useful compounds can be found in bacteria that share similar requirements for antibiotics with humans, and focus on Photorhabdus symbionts of entomopathogenic nematode microbiomes. Here we report a new antibiotic that we name darobactin, which was obtained using a screen of Photorhabdus isolates. Darobactin is coded by a silent operon with little production under laboratory conditions, and is ribosomally synthesized. Darobactin has an unusual structure with two fused rings that form post-translationally. The compound is active against important Gram-negative pathogens both in vitro and in animal models of infection. Mutants that are resistant to darobactin map to BamA, an essential chaperone and translocator that folds outer membrane proteins. Our study suggests that bacterial symbionts of animals contain antibiotics that are particularly suitable for development into therapeutics.Keywords
This publication has 55 references indexed in Scilit:
- In Vitro and In Vivo Characterization of NOSO-502, a Novel Inhibitor of Bacterial TranslationAntimicrobial Agents and Chemotherapy, 2018
- Sequence-Specific Solution NMR Assignments of the β-Barrel Insertase BamA to Monitor Its Conformational Ensemble at the Atomic LevelJournal of the American Chemical Society, 2018
- Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysisJournal of Infection, 2018
- Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal SiteMolecular Cell, 2018
- Predictive compound accumulation rules yield a broad-spectrum antibioticNature, 2017
- Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniaeAnnals of Clinical Microbiology and Antimicrobials, 2017
- The structure of the β-barrel assembly machinery complexScience, 2016
- A new antibiotic kills pathogens without detectable resistanceNature, 2015
- Platforms for antibiotic discoveryNature Reviews Drug Discovery, 2013
- Drugs for bad bugs: confronting the challenges of antibacterial discoveryNature Reviews Drug Discovery, 2006